Enter assignee name

EPO Patents = 4

Forward Citations = 16

Loading Chart...

9 inventors (with patents filed for the assignee):

Garth Cumberlidge (5 out of 5 patents)

Karen Meerovitch (5 out of 5 patents)

Teresa Lama (5 out of 5 patents)

4. Sébastien Rocchi (3 out of 4 patents)

5. Chantal Devin (3 out of 4 patents)

6. Wei Tian (3 out of 5 patents)

7. Martin Hans Bohlin (3 out of 28 patents)

8. Horacio Uri Saragovi (2 out of 8 patents)

9. Jeanick Pascal (1 out of 4 patents)

10. H Uri Saragovi (4 patents)

11. Uri H Saragovi (6 patents)

9 patents: Sort by Forward Citations

1. 11753441 - Solution phase synthesis of beta-turn peptidomimetic cyclic salts (2023-09-12),

2. 11078234 - Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts (2021-08-03),

3. 10125165 - Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts (2018-11-13),

4. 9707267 - Beta-turn peptidomimetic cyclic compounds for treating dry eye (2017-07-18),

5. 9156882 - Beta-turn peptidomimetic cyclic compounds for treating dry eye (2015-10-13),

6. 9115179 - Synthesis of beta-turn peptidomimetic cyclic compounds (2015-08-25),

7. 8748391 - β-turn peptidomimetic cyclic compounds for treating dry eye (2014-06-10),

8. 8653036 - Methods of treating retinitis pigmentosa (2014-02-18),

9. 8293713 - Beta-turn peptidomimetic cyclic compounds for treating dry eye (2012-10-23),

Mimetogen Pharmaceuticals, Inc is a biopharmaceutical company that focuses on developing innovative therapies for ocular diseases. The company's lead product candidate is MIM-D3, a novel small molecule designed to treat dry eye syndrome. Mimetogen is committed to improving the quality of life for patients with ophthalmic disorders through cutting-edge research and the development of breakthrough treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

9 Patents

#107 in Montreal

#1,636 in Canada

Montreal, Canada

Mimetogen Pharmaceuticals, Inc